Patents by Inventor Balvir SINGH

Balvir SINGH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended release pharmaceutical composition of Clozapine
    Patent number: 11833253
    Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: December 5, 2023
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Mayank Saxena, Rikin Patel, Piyush Kansagra, Balvir Singh, Ashish Sehgal
  • Extended release pharmaceutical composition of clozapine
    Patent number: 11504336
    Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.
    Type: Grant
    Filed: September 16, 2017
    Date of Patent: November 22, 2022
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Mayank Saxena, Rikin Patel, Piyush Kansagra, Balvir Singh, Ashish Sehgal
  • ORALLY DISINTEGRATING PHARMACEUTICAL COMPOSITIONS OF APIXABAN
    Publication number: 20220211689
    Abstract: The present invention relates to an orally disintegrating pharmaceutical dosage forms of apixaban or a pharmaceutically acceptable salt or prodrug thereof. The present invention specifically relates to a stable orally disintegrating pharmaceutical composition comprising apixaban and one or more pharmaceutically acceptable excipients. Further, the present invention relates to an orally disintegrating dosage form comprising apixaban, at least one disintegrating excipient and optionally one or more pharmaceutically acceptable excipients for treatment of disorders associated with Factor Xa.
    Type: Application
    Filed: October 31, 2020
    Publication date: July 7, 2022
    Applicant: UNISON PHARMACEUTICALS PVT. LTD.
    Inventors: Balvir SINGH, Ramesh SHINGALA, Shivang PRAJAPATI
  • EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF CLOZAPINE
    Publication number: 20200054573
    Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.
    Type: Application
    Filed: September 16, 2017
    Publication date: February 20, 2020
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Mayank SAXENA, Rikin PATEL, Piyush KANSAGRA, Balvir SINGH, Ashish SEHGAL
  • TABLET-IN-TABLET PHARMACEUTICAL COMPOSITION COMPRISING CYCLOPHOSPHAMIDE AND CAPECITABINE
    Publication number: 20190142755
    Abstract: A stable tablet-in-tablet pharmaceutical composition having fixed dose combinations of cyclophosphamide and capecitabine and one or more pharmaceutically acceptable excipient. As disclosed is a process for the preparation thereof, and a method their use in treating cancer diseases.
    Type: Application
    Filed: May 2, 2017
    Publication date: May 16, 2019
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Priyank PATEL, Mayur PATEL, Mahendra PATEL, Balvir SINGH, Ashish SEHGAL
  • Pharmaceutical composition having improved content uniformity
    Patent number: 10016447
    Abstract: This present invention relates to pharmaceutical compositions comprising cyclophosphamide alone and/or in combination with one or more pharmaceutical active ingredients and one or more pharmaceutically acceptable excipients wherein the cyclophosphamide has D90 particle size less than 100 microns.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: July 10, 2018
    Assignee: Intas Pharmaceuticals Ltd.
    Inventors: Priyank Patel, Mayur Patel, Mahendra Patel, Balvir Singh, Ashish Sehgal
  • PHARMACEUTICAL COMPOSITION HAVING IMPROVED CONTENT UNIFORMITY
    Publication number: 20170304328
    Abstract: This present invention relates to pharmaceutical compositions comprising cyclophosphamide alone and/or in combination with one or more pharmaceutical active ingredients and one or more pharmaceutically acceptable excipients wherein the cyclophosphamide has D90 particle size less than 100 microns.
    Type: Application
    Filed: September 25, 2015
    Publication date: October 26, 2017
    Inventors: Priyank PATEL, Mayur PATEL, Mahendra PATEL, Balvir SINGH, Ashish SEHGAL
  • PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE AND CYCLOPHOSPHAMIDE
    Publication number: 20160243034
    Abstract: A pharmaceutical compositions having fixed dose combinations of capecitabine and cyclophosphamide, processes for the preparation thereof, and their use to treat cancer diseases.
    Type: Application
    Filed: September 29, 2014
    Publication date: August 25, 2016
    Applicant: INTAS PHARMACEUTICALS LIMITED
    Inventors: Priyank PATEL, Mayur PATEL, Mahendra PATEL, Balvir SINGH, Ashish SEHGAL